USANA Health Sciences (USNA) vs. Its Peers Financial Comparison

USANA Health Sciences (NYSE:USNA) is one of 55 publicly-traded companies in the “Personal Care Products” industry, but how does it contrast to its peers? We will compare USANA Health Sciences to related businesses based on the strength of its institutional ownership, analyst recommendations, risk, profitability, dividends, valuation and earnings.

Profitability

This table compares USANA Health Sciences and its peers’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
USANA Health Sciences	-2.34%	3.56%	2.62%
USANA Health Sciences Competitors	-4.65%	-66.48%	-0.41%

Analyst Ratings

This is a breakdown of current ratings for USANA Health Sciences and its peers, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
USANA Health Sciences	2	0	0	0	1.00
USANA Health Sciences Competitors	898	2932	3658	228	2.42

As a group, “Personal Care Products” companies have a potential upside of 1.69%. Given USANA Health Sciences’ peers stronger consensus rating and higher possible upside, analysts clearly believe USANA Health Sciences has less favorable growth aspects than its peers.

Institutional & Insider Ownership

54.2% of USANA Health Sciences shares are held by institutional investors. Comparatively, 48.6% of shares of all “Personal Care Products” companies are held by institutional investors. 0.8% of USANA Health Sciences shares are held by company insiders. Comparatively, 11.7% of shares of all “Personal Care Products” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Earnings and Valuation

This table compares USANA Health Sciences and its peers gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
USANA Health Sciences	$913.36 million	$10.76 million	-12.09
USANA Health Sciences Competitors	$7.94 billion	$1.11 billion	9.08

USANA Health Sciences’ peers have higher revenue and earnings than USANA Health Sciences. USANA Health Sciences is trading at a lower price-to-earnings ratio than its peers, indicating that it is currently more affordable than other companies in its industry.

Risk & Volatility

USANA Health Sciences has a beta of 0.66, indicating that its share price is 34% less volatile than the S&P 500. Comparatively, USANA Health Sciences’ peers have a beta of 0.80, indicating that their average share price is 20% less volatile than the S&P 500.

Summary

USANA Health Sciences peers beat USANA Health Sciences on 9 of the 13 factors compared.

About USANA Health Sciences

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.